These press releases are intended for business journalists
and analysts/investors.
27 January 2012
GSK announces changes to the Board
09 January 2012
GSK and Theravance announce initial outcomes from pivotal Phase III studies for once-daily RelovairTM* in COPD and asthma
20 December 2011
GlaxoSmithKline provides update on divestment of non-core over-the-counter (OTC) brands
Investors